๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Secondary myelodysplastic syndrome after hydroxychloroquine therapy

โœ Scribed by Alaa A. Muslimani; Timothy P. Spiro; Asif A. Chaudhry; Hamed A. Daw

Publisher
Springer
Year
2007
Tongue
English
Weight
91 KB
Volume
86
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Myelodysplastic syndrome after cisplatin
Myelodysplastic syndrome after cisplatin therapy
โœ R. Cheruku; M. Hussain; M. Tyrkus; M. Edelstein ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 542 KB

Therapy-related myelodysplastic syndrome (tMDS) and acute nonlymphocytic leukemia (tANLL) are known late complications of cytotoxic drug therapy for hematologic malignancies, solid tumors, and nonmalignant conditions. The alkylating agents are often the causative agents, but a few reports have impli

Novel therapies for myelodysplastic synd
Novel therapies for myelodysplastic syndromes
โœ Stefan Faderl; Hagop M. Kantarjian ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 209 KB

## Abstract ## BACKGROUND The assessment of patients with myelodysplastic syndromes (MDS) and the choice of therapies remain challenging. New therapies are now emerging after the identification of molecular targets that result in improvement of hematologic parameters and may hold promise for the p

Immunosuppressive therapy for hypoplasti
Immunosuppressive therapy for hypoplastic myelodysplastic syndrome
โœ Douwe H. Biesma; Jan G. van den Tweel; Leo F. Verdonck ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 199 KB ๐Ÿ‘ 1 views

## Background: Hypoplastic myelodysplastic syndrome (mds) is characterized by dysplasia and hypocellularity. the treatment of choice for young patients is bone marrow transplantation. ## Methods: This report describes the effect of immunosuppressive therapy in two patients with hypoplastic mds fo